Illumina (ILMN) Stock: Buy, Sell, or Hold?
$207.01
-2.54 (-1.21%)
▼
5d:
-2.87%
30d:
-22.74%
90d:
+7.18%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Oct 29, 2026
0d
Protect ILMN Gains
Updated Nov 13, 12:00 AM ET
QUANTITATIVE VERDICT
HOLD
LOW Confidence (91%)
Quality Score
59/100
Position
OVERSOLD
30-Day Fair Range
$226.04 – $282.17
Position: OVERSOLD
Forward P/E & Valuation
33.5x
FAIR
vs 29.6x historical avg
Wall Street Target
$261.45
+26.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$197.81 / $244.05
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: ILMN is fairly valued with market pricing in 4.2% annual growth. Fine to hold or accumulate slowly on dips.
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Nov 5, 2026 at $214.65 · last confirmed Nov 9, 2026
Strength: 6.5/10
Get Alerted When ILMN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$230.87
Based on 8.4% avg growth
INTRINSIC VALUE TODAY
$143.35
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ILMN is currently trading at $207.01, which is considered oversold relative to its 30-day fair value range of $226.04 to $282.17. From a valuation perspective, the stock is trading at a premium (Forward PE: 33.5) compared to its historical average (29.6). At these levels, the market is pricing in 4.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ILMN is in a strong uptrend. Immediate support is located at $197.81, while resistance sits at $244.05.
Market Sentiment: ILMN scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $261.45 (+26.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ILMN is in a strong uptrend. Immediate support is located at $197.81, while resistance sits at $244.05.
Market Sentiment: ILMN scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $261.45 (+26.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$226.04 -
$282.17
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
91.4%
Trading Range & Key Levels
30-Day Trading Range
$226.04 -
$282.17
Current vs Trading Range
OVERSOLD
Support Level
$197.81
Resistance Level
$244.05
Current Trend
Strong Uptrend
Technical data as of
Nov 13, 2026
Protect Your Profits
Holding ILMN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 26.3% below Wall St target ($261.45)
- NEUTRAL: Market pricing in 4.2% annual earnings growth - fairly valued
- CAUTION: Bottoming setup, but lagging the sector by 11% over 20 days — wait for relative strength
Fundamental Context
Forward P/E (Next Year Est.)
33.48
Wall Street Target
$261.45
(+26.3%)
Revenue Growth (YoY)
4.2%
Earnings Growth (YoY)
45.9%
Profit Margin
19.7%
Valuation Premium vs History
+4.2% premium
PE vs Historical
33.5 vs 29.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.2%
(market-implied from PE analysis)
1-Year Target
$215.70
(+4%)
2-Year Target
$224.76
(+9%)
3-Year Target
$234.20
(+13%)
3-Yr Target (if PE normalizes)
(PE: 33→30)
PE COMPRESSION
$207.05
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 33.5, Growth: 12.8%)
$297.11
(+44%)
Base:
(SPY PE: 19.9, Growth: 12.8%)
$176.23
(-15%)
Bear:
(PE: 16.9, Growth: 12.8%)
$149.80
(-28%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (37x PE), but valuation improves significantly next year (33x PE) as earnings recover.
Trailing PE: 36.63 | Current EPS (TTM): $5.72
Bull Case
$249.15
(+20%)
Analyst growth 8.1%, PE expands to 40.3
Base Case
$226.50
(+9%)
Market implied 8.1%, PE stable at 36.6
Bear Case
$142.49
(-31%)
Severe decline -20.0%, PE contracts to 31.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share ILMN Analysis
Share this live ILMN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ILMN)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 4, 2026
Daily AI digest
AI Retail Discussion Summary:
Illumina ($ILMN) was selected for Singapore's SG-INSIGHT genome sequencing project covering 450,000 people, reinforcing its role as a key supplier for large population genomics.
Key Retail Themes:
Illumina's role as a supplier for large-scale population genomics projects
SG-INSIGHT's potential impact on Illumina's revenue and margin mix
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 14, 2026 5:46 AM ET
Data refreshes hourly during market hours. Next update: 6:46 AM
Data refreshes hourly during market hours. Next update: 6:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ILMN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$201 | 57 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$416 | 67 BUY |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
27 analysts |
$752 | 52 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
24 analysts |
$260 | 52 HOLD |
Advanced ILMN Option Strategies
Professional options setups generated by AI based on today's ILMN price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ILMN Research Pages
